Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth ...

Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently talked about. Cramer mentioned the stock and said that he liked its quarter. He remarked: “What do we make of the numbers that we ...

Q2 2025 Management View Chairman and CEO Phillip Frost reported that OPKO Health is advancing its strategic initiatives, highlighting the pending sale of BioReference Health's oncology and related ...

Trump gave the companies 60 days to voluntarily comply, threatening to "deploy every tool in our arsenal to protect American ...

U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate ...

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

Merck will reduce its workforce by approximately 6,000 employees in “some areas of our global workforce,” the New Jersey ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Drug maker Merck announced Tuesday it will embark on an initiative to cut $3 billion in costs 2027, including an undisclosed ...

With Bitcoin reaching record levels this year, Strategy's stock has benefited from the growing popularity of the top ...

Merck & Co., Inc. (NYSE: MRK) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, ...

Employees of the technology transfer centre ANAXAM and researchers from the Paul Scherrer Institute PSI used the unique ...